Edition:
United States

Selvita SA (SLVP.WA)

SLVP.WA on Warsaw Stock Exchange

55.10PLN
23 May 2018
Change (% chg)

-- (--)
Prev Close
55.10zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,458
52-wk High
70.00zł
52-wk Low
39.00zł

Chart for

About

Selvita SA is a Poland-based company engaged in the healthcare industry. The Company is active in the pharmaceutical and biotechnology fields. It operates through two business segments. The Innovative segment develops new drugs mainly for oncology and central nervous system diseases. The Services segment is engaged in the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.23
Market Cap(Mil.): zł908.76
Shares Outstanding(Mil.): 15.97
Dividend: --
Yield (%): --

Financials

  SLVP.WA Industry Sector
P/E (TTM): 122.30 237.88 32.90
EPS (TTM): 0.47 -- --
ROI: 9.29 -7.38 12.74
ROE: 10.89 -10.11 14.64

BRIEF-Selvita Q1 Net Profit Up At 20.0 Mln Zlotys

* REPORTED ON TUESDAY Q1 NET PROFIT OF 20.0 MILLION ZLOTYS VERSUS 5.2 MILLION ZLOTYS YEAR AGO

May 23 2018

BRIEF-Selvita FY Net Profit Up At 6.4 Mln Zlotys

* REPORTED ON TUESDAY FY NET PROFIT OF 6.4 MILLION ZLOTYS VERSUS 2.7 MILLION ZLOTYS YEAR AGO

Mar 28 2018

BRIEF- Pawel Przewiezlikowski Lowers Stake In Selvita To 31.25%

* SAID ON TUESDAY PAWEL PRZEWIEZLIKOWSKI LOWERED HIS STAKE IN COMPANY TO 31.25 PERCENT FORM 36.24 PERCENT FOLLOWING COMPANY'S SHARE CAPITAL INCREASE

Mar 21 2018

BRIEF-PFR Life Science Buys Shares Of Selvita For Around 40 Mln Zlotys

* SAYS THAT PFR LIFE SCIENCE ACQUIRED COMPANY'S SHARES WORTH AROUND 40 MILLION ZLOTYS IN PUBLIC OFFER

Mar 01 2018

BRIEF-Selvita Sets Final Price Of 2.2 Mln Series H Shares At 61 Zlotys/Shr

* SAID ON THURSDAY THE COMPANY SET FINAL PRICE OF 2.2 MLN SERIES H SHARES AT 61 ZLOTYS PER SHARE

Feb 16 2018

BRIEF-Selvita Sets Share Price At 61 Zlotys/Shr

* SAID ON WEDNESDAY THAT IT HAS SET THE PRICE FOR THE ISSUE OF UP TO 2.2 MILLION H SERIES SHARES AT 61 ZLOTYS PER SHARE

Feb 01 2018

BRIEF-Selvita: KNF Approves Prospectus On Issuance Of 2.2 Mln Series H Shares

* KNF APPROVES PROSPECTUS ON NEW ISSUANCE OF 2.2 MILLION SERIES H SHARES IN PUBLIC OFFER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jan 31 2018

BRIEF-Selvita Says FDA Allows To Resume Clinical Trial Of SEL24

* SAID ON SATURDAY THE FOOD AND DRUG ADMINISTRATION (FDA) HAS ALLOWED THE COMPANY TO RESUME CLINICAL TRIAL OF SEL24 PHASE I/II, CARRIED OUT IN U.S. WITH PATIENTS SUFFERING FROM ACUTE MYELOID LEUKEMIA

Dec 18 2017

BRIEF-Selvita To Get 30 Mln Zloty Financing from NCBiR

* SIGNS DEAL WITH NCBIR ON FINANCING CO'S PROJECT WITH 30 MILLION ZLOTYS

Dec 13 2017

Earnings vs. Estimates